Publicacións nas que colabora con Pablo Aguiar Fernández (15)

2022

  1. 18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 4, pp. 1242-1253

2020

  1. Prolonged Migraine Stuttering Aura: Structural, Functional, and Video Neuroimaging Study of an Atypical Migraine Aura. A Case Report

    Headache, Vol. 60, Núm. 4, pp. 776-780

  2. White matter hyperintensities are associated with subthreshold amyloid accumulation

    NeuroImage, Vol. 218

2019

  1. Prediction of Alzheimer's disease dementia with MRI beyond the short-term: Implications for the design of predictive models

    NeuroImage: Clinical, Vol. 23

  2. Staging the cognitive continuum in prodromal Alzheimer's disease with episodic memory

    Neurobiology of Aging, Vol. 84, pp. 1-8

2017

  1. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323

  2. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36

    Movement Disorders, Vol. 32, Núm. 2, pp. 264-273

2016

  1. A method for estimating DMSA SPECT renal function for assessing the effect of percutaneous nephrolithotripsy on the treated pole

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 60, Núm. 2, pp. 154-162

  2. Impact of benzodiazepines on brain FDG-PET quantification after single-dose and chronic administration in rats

    Nuclear Medicine and Biology, Vol. 43, Núm. 12, pp. 827-834

  3. Iterative Structural and Functional Synergistic Resolution Recovery (iSFS-RR) Applied to PET-MR Images in Epilepsy

    IEEE Transactions on Nuclear Science, Vol. 63, Núm. 5, pp. 2434-2442

2015

  1. Invivo quantification of renal function in mice using clinical gamma cameras

    Physica Medica, Vol. 31, Núm. 3, pp. 242-247

2014

  1. Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies

    Medical Physics, Vol. 41, Núm. 5

  2. Does percutaneous nephrolithotomy and its outcomes have an impact on renal function? Quantitative analysis using SPECT-CT DMSA

    Urolithiasis, Vol. 42, Núm. 5, pp. 461-467

  3. Substraction acetazolamide SPECT co-registered to MRI in moyamoya disease: quantitative cerebrovascular reserve map.

    Clinical nuclear medicine, Vol. 39, Núm. 4, pp. 399-401

2012

  1. Familial hemiplegic migraine with prolonged global aura: Follow-up findings of subtraction ictal SPECT co-registered to MRI (SISCOM)

    Cephalalgia, Vol. 32, Núm. 13, pp. 1013-1014